eXoZymes (NASDAQ:EXOZ) Stock Price Down 2.5% – Here’s Why

eXoZymes Inc. (NASDAQ:EXOZ) shares dropped 2.5% during trading on Friday . The stock traded as low as $9.76 and last traded at $9.7690. Approximately 172 shares were traded during mid-day trading, a decline of 93% from the average daily volume of 2,482 shares. The stock had previously closed at $10.02.

eXoZymes Stock Performance

The company has a debt-to-equity ratio of 0.02, a quick ratio of 2.51 and a current ratio of 2.51. The stock’s 50-day simple moving average is $9.11 and its two-hundred day simple moving average is $11.09. The stock has a market cap of $82.84 million, a price-to-earnings ratio of -8.57 and a beta of 2.85.

eXoZymes (NASDAQ:EXOZ) last posted its quarterly earnings data on Thursday, May 14th. The company reported ($0.28) EPS for the quarter.

About eXoZymes

eXoZymes, Inc develops, manufactures and supplies a range of enzymes and reagents designed for molecular biology research and diagnostic applications. The company’s enzyme engineering platform underpins a portfolio of products aimed at supporting nucleic acid purification, amplification and analysis workflows.

Key offerings from eXoZymes include magnetic bead–based nucleic acid extraction kits, DNA polymerases, reverse transcriptases, proteases and custom enzyme services. In addition, the company provides molecular diagnostic test kits designed for pathogen detection, leveraging scalable production processes and quality systems aligned with regulatory standards.

eXoZymes serves academic research institutions, biotechnology and pharmaceutical companies, and clinical diagnostic laboratories worldwide.